Determination That TOVALT ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that TOVALT ODT (zolpidem tartr...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- July 9, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA, Agency, or we) has determined that TOVALT ODT (zolpidem tartr...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Astral 150â„¢
An internal electrical component (supercapacitor) may leak electrolyte over time. In rare cases, thi...
Environmental monitoring following the Grenfell Tower fire
Air quality reports for the survivors and residents of the area surrounding Grenfell Tower.
UKHSA updates heat health alerts across England
Amber heat-health alerts are now in place across all regions of England except the North East, which...
DHSC spending over £25,000
This series brings together all documents relating to Department of Health and Social Care (DHSC) sp...